Capitan Orthopedics, Inc. Announces the Closing of Their Oversubscribed Seed Round

Capitan Orthopedics has closed an oversubscribed Seed round, bringing total capital raised to $4.1 million, and plans to begin its first in-human trial of the SupraSpacer™ shoulder implant in Q1 2027.